Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Assess the Safety and Performance of the Discure Technologies System for the Treatment of Early to Moderate Degenerative Disc Disease (DDD).

NCT06127745 is registered in ClinicalTrials.gov with Discure Technologies Ltd. as lead sponsor.

NCT NCT06127745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06127745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Assess the Safety and Performance of the Discure Technologies System for the Treatment of Early to Moderate Degenerative Disc Disease (DDD).
Lead sponsor
Discure Technologies Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2024
Completion date
December 31, 2024
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low-back pain, degenerative disc disease, discogenic pain